<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Urinary levels of alpha 1-microglobulin (alpha 1M) and of ulinastatin (UT) and the alpha 1M/UT ratio did not differ significantly between age-matched controls and patients with <z:e sem="disease" ids="C0030567" disease_type="Disease or Syndrome" abbrv="PD">Parkinson's disease</z:e>, and among subdivided groups based on Yahr's stages in <z:e sem="disease" ids="C0030567" disease_type="Disease or Syndrome" abbrv="PD">Parkinson's disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Furthermore, these indexes did not correlate with Yahr's stages </plain></SENT>
<SENT sid="2" pm="."><plain>Although alpha 1M and UT levels did not correlate in patients with <z:e sem="disease" ids="C0030567" disease_type="Disease or Syndrome" abbrv="PD">Parkinson's disease</z:e>, a positive correlation was observed in the control group </plain></SENT>
<SENT sid="3" pm="."><plain>The non-existence of a positive correlation between alpha 1M and UT levels distinguishes <z:e sem="disease" ids="C0030567" disease_type="Disease or Syndrome" abbrv="PD">Parkinson's disease</z:e> from other neuropsychiatric diseases such as <z:hpo ids='HP_0000726'>dementia</z:hpo> (Alzheimer-type and vascular <z:hpo ids='HP_0000726'>dementia</z:hpo>), <z:hpo ids='HP_0100753'>schizophrenia</z:hpo> and <z:e sem="disease" ids="C0525045" disease_type="Mental or Behavioral Dysfunction" abbrv="">mood disorder</z:e> </plain></SENT>
</text></document>